Merck & Co., Inc. Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31)
Merck & Co., Inc. (MRK) reported Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) of 2.3 Y for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition · last filed 2012-05-08
- Merck & Co., Inc. employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition (deprecated 2012-01-31) for the quarter ending 2012-03-31 was 2.30 Y.
- Merck & Co., Inc. employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition (deprecated 2012-01-31) for fiscal 2011 was 1.80 Y.
Y
| Period end | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 3 month | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 12 month |
|---|---|---|
| 2012-03-31 | 2.30 Y 10-Q · filed 2012-05-08 | |
| 2011-12-31 | 1.80 Y 10-K · filed 2012-02-28 |
Year
| Period end | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 9 month |
|---|---|
| 2011-09-30 | 1.90 Year 10-Q · filed 2011-11-08 |
Years
| Period end | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 6 month |
|---|---|
| 2011-06-30 | 2.10 Years 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |